Inscription Capital, LLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 1767868 HOUSTON, TX

Position in ANIK

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$145,232

+$23,512 QoQ

Shares Held

10,016

-20.9% QoQ

Ownership

0.075%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Inscription Capital, LLC holds $1,401,582 across 5 Drug Manufacturers - Specialty & Generic names. ANIK ranks #4 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	20,099	$480,969
2	TAK	Takeda Pharmaceutical Co Ltd	22,011	$407,643
3	ZTS	Zoetis Inc.	2,024	$239,257
4	ANIK	Anika Therapeutics, Inc. This page	10,016	$145,232
5	BCRX	Biocryst Pharmaceuticals Inc	13,496	$128,481

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$145,232	10,016	-20.9%	Shares	Sole	2026-04-20
2025-12-31	$121,720	12,666	—	Shares	Sole	2026-01-29
No filing history on record for this holder in this stock.